Jan Anderl
Impact in
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 9
- Oncology 8
- HER2/EGFR in Cancer Research 8
- Co-authors
- Heinz Faulstich (3 shared papers)Gerhard Moldenhauer (1 shared paper)Alexei V. Salnikov (1 shared paper)Ingrid Herr (1 shared paper)Christian Lutz (2 shared papers)Tobias V. Lanz (1 shared paper)Ulrike Litzenburger (1 shared paper)Isabel Tritschler (1 shared paper)
- Journals
- Cancer Research (5 papers)Bioconjugate Chemistry (4 papers)Nature (2 papers)Beilstein Journal of Organic Chemistry (1 paper)Stem Cells (1 paper)
- Partner nations
- GermanyUnited StatesChina
In The Last Decade
Jan Anderl
18 papers receiving 818 citations
Peers
Comparison fields: 5 of 77
- Genetics 204
- Oncology 317
- Radiology, Nuclear Medicine and Imaging 199
- Immunology 144
- Biological Psychiatry 16
Countries citing papers authored by Jan Anderl
This map shows the geographic impact of Jan Anderl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Anderl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Anderl more than expected).
Fields of papers citing papers by Jan Anderl
This network shows the impact of papers produced by Jan Anderl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Anderl. The network helps show where Jan Anderl may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan Anderl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 269 | |
| 2 | 2015 | 179 | |
| 3 | 2012 | 163 | |
| 4 | 2013 | 63 | |
| 5 | 2020 | 48 | |
| 6 | 2012 | 34 | |
| 7 | 2021 | 25 | |
| 8 | 2022 | 19 | |
| 9 | 2014 | 13 | |
| 10 | 2023 | 10 | |
| 11 | 2014 | 8 | |
| 12 | 2011 | 6 | |
| 13 | 2024 | 5 | |
| 14 | 2024 | 4 | |
| 15 | 2021 | 3 | |
| 16 | 2024 | 3 | |
| 17 | 2025 | 1 | |
| 18 | 2015 | 1 |
About Jan Anderl
Jan Anderl is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Immunology, having authored 18 papers that have together received 854 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (9 papers), HER2/EGFR in Cancer Research (8 papers), Silymarin and Mushroom Poisoning (3 papers), RNA Interference and Gene Delivery (3 papers), Glycosylation and Glycoproteins Research (2 papers), Toxin Mechanisms and Immunotoxins (2 papers), Virus-based gene therapy research (1 paper) and Flavonoids in Medical Research (1 paper). The work is most often cited by research in Genetics (204 citations), Oncology (317 citations), Radiology, Nuclear Medicine and Imaging (199 citations), Immunology (144 citations) and Biological Psychiatry (16 citations). Jan Anderl has collaborated with scholars based in Germany, United States and China. Frequent co-authors include Heinz Faulstich, Gerhard Moldenhauer, Alexei V. Salnikov, Ingrid Herr, Christian Lutz, Tobias V. Lanz, Ulrike Litzenburger, Isabel Tritschler, M. Hoberg and Wilhelm K. Aicher. Their work appears in journals such as Cancer Research, Bioconjugate Chemistry, Nature, Beilstein Journal of Organic Chemistry and Stem Cells.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.